The asset is one thing, drill bit will do the talking and the area looks pretty good. Straws issue is the terms or how the deal was structured with regards to management and brokers and you can't argue fees and pricing isn't excessive
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025